Global Cataract Surgery Devices Market was valued at USD 7.34 billion in 2020, growing at a CAGR of 5.49% during the forecast period from 2021 to 2026 to reach USD 10.08 billion by 2026. The demand for cataract surgery devices is primarily being boosted by rising geriatric population base, growing prevalence of lifestyle disorders such as hypertension and diabetes, increasing prevalence of cataract, and technical innovation in product development
They are expected to drive the product demand thereby contributing to the growth of the cataract surgery devices market during the forecast period from 2021-2026.
Some of the Global Cataract Surgery companies with their cataract surgery products various stages of development includes Alcon Inc (Novartis), Johnson & Johnson Vision Care, Inc., NIDEK CO., LTD, ZEISS Group, Bausch & Lomb Incorporated, ROWIAK GmbH, Ziemer Ophthalmic Systems, HOYA Corporation, CRISTALENS, Aurolab, Hanita Lenses, Altacor, Bohus BioTech AB, Eyekon Medical, CIMA Technology Inc, i-Medical® Ophthalmic International Heidelberg GmbH, Medisonic Equipments Pvt. Ltd., OPTIKON SpA, MEDA Co., Ltd, STAAR SURGICAL, and others are currently dominating the Cataract Surgery Market.
DelveInsight’s “Cataract Surgery Devices Market Insights and Forecast” report provides the current and forecasted Cataract Surgery Devices Market trends for the next five years, upcoming innovation in the devices, individual Cataract Surgery Devices market share, challenges, drivers and barriers, and key competitors in the domain.
Cataract Surgery Devices: An Overview
Cataract surgery devices are medical devices that are employed during the cataract surgery and carry out tasks in different steps during the surgery such as breaking of the cataract into small pieces which is performed by phacoemulsification devices and the replacement by the artificial lens such as intraocular lenses among other products.
Are you interested to know how the Cataract surgery devices market will be growing by 2026? If yes, click to get a snapshot of the Cataract Surgery Steps With Instruments
Recent Breakthroughs in Cataract Surgery Devices Market
In recent years, the cataract surgery device market observed expansions in terms of clinical, commercial, and clinical development.
- In June 2021, Johnson & Johnson Vision announced the launch of their Veritas Vision System for cataract surgery. The product was launched in the United States, Europe, and select markets in the Asia-Pacific region.
- In April 2021, the US Food and Drug Administration granted the product approval to Bausch and Laumb’s ophthalmic viscosurgical device– ClearVisc™ Dispersive Ophthalmic Viscosurgical Device.
- In January 2021, Alcon Inc, a subsidiary of Novartis, launched the AcrySof IQ Vivity, the first and only non-diffractive extended depth of focus intraocular lens in the United States.
According to DelveInsight, the Cataract Surgery Device Clinical Development market would rise rapidly throughout the forecast period due to continuous commercial and clinical development.
Key Players Proactively working in the Cataract Surgery Devices Market Insights
The global market for Cataract Surgery Devices key players contribute significantly to their development and are also active in mergers and acquisitions to strengthen their market position.
Some of the Cataract Surgery Devices market companies operating actively in the cataract surgery device included Alcon Inc (Novartis), Johnson & Johnson Vision Care, Inc., NIDEK CO., LTD, ZEISS Group, Bausch & Lomb Incorporated, ROWIAK GmbH, Ziemer Ophthalmic Systems, HOYA Corporation, CRISTALENS, Aurolab, Hanita Lenses, Altacor, Bohus BioTech AB, Eyekon Medical, CIMA Technology Inc, and others
Learn more about the Cataract Surgery Devices, get in-depth information @ Cataract Surgery Instruments List
COVID-19 Impact Analysis on Cataract Surgery Devices Market
In addition to the previously mentioned factors, the cataract surgery devices market witnessed a period of temporary setback owing to the imposing of the lockdown restrictions as necessary measures to contain the COVID-19 spread. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for cataract surgery devices in the market as cataract surgery was deemed non-essential during the initial lockdown period, thereby limiting the Cataract Surgery Devices market growth for a short time.
Nevertheless, the market for cataract surgery devices is in the period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for cataract surgery devices market during the forecast period. However, limited coverage by health insurers as well as technique-associated complications may restrict the cataract surgery devices market growth.
Request a snapshot of the report, just a click here to know @ Second Instrument Cataract Surgery
Scope of the Cataract Surgery Devices Market Report
- Geography Covered- Global
- Study period- 2021-2026
- Market Segmentation- By Product Type, By End-user, By Geography and rest of the world
- Key Global Cataract Surgery Devices Market Companies:- Alcon Inc (Novartis) (NYSE: ALC), Johnson & Johnson Vision Care, Inc.(NYSE: JNJ), NIDEK CO., LTD (NYSE: NJDSY), ZEISS Group, Bausch & Lomb Incorporated (NYSE: BOL), ROWIAK GmbH, Ziemer Ophthalmic Systems, HOYA Corporation (NYSE: HOCPF), CRISTALENS, Aurolab, Hanita Lenses, Altacor, Bohus BioTech AB, Eyekon Medical, CIMA Technology Inc, and others.
- Porter’s Five Forces Analysis, Product Profiles, Cases Studies, KOL’s Views, a0nd Analyst’s View
Table of content
- Report Introduction
- Executive Summary
- Regulatory and Patent Analysis
- Key Factors Analysis
- Porter’s Five Forces Analysis
- COVID-19 Impact Analysis
- Layout
- Global Company Share Analysis – Key 3-5 Companies
- Company and Product Profiles
- Project Approach
- KOL Views
- DelveInsight Capabilities
- Disclaimer
- About DelveInsight
For more details about the market size of Cataract Surgery Device, just click here @ Cataract Surgery Instruments Set
Key Takeaways from the Cataract Surgery Devices Market Report Study
- Market size analysis for current Cataract Surgery Devices market size (2020), and market forecast for 5 years (2021-2026)
- The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Cataract Surgery Devices market.
- Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
- Various opportunities are available for the other competitor in the arthroscopy devices market space and dominating the global Cataract Surgery Devices market companies
- Which are the top-performing segments, regions, and countries in the current Cataract Surgery Devices market scenario in 2020?
- Which are the regions and countries where companies should have concentrated on opportunities for Cataract Surgery Devices market growth in the coming future?
Are you interested to get information about the cataract surgery device market? If yes, you are just one click away @ Cataract Surgery Devices Regulatory and Patent Analysis
Related Reports
Cataract Surgery Complications Market
DelveInsight’s Cataract Surgery Complications report delivers an in-depth understanding of the Cataract Surgery Complications, historical and forecasted epidemiology as well as the Cataract Surgery Complications market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Cataract Surgery Complications companies involved such as Noveome Biotherapeutics and others
DelveInsight’s Cataract report delivers an in-depth understanding of the Cataract, historical and forecasted epidemiology as well as the Cataract market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan
Post-Operative Cataract Surgery Inflammation Market
DelveInsight’s Post-Operative Cataract Surgery Inflammation report delivers an in-depth understanding of the Cataract, historical and forecasted epidemiology as well as the Post-Operative Cataract Surgery Inflammation market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Post-Operative Cataract Surgery Inflammation companies involved such as Eyepoint Pharmaceuticals, Alcon Research, Oculis Pharma, Formosa Pharmaceuticals, and others.
Related Blogs by DelveInsight
- Cataract Surgery Devices Market Awareness by Delveinsight
- How Pharmaceutical Companies Are Mitigating The Gap In The Eye Disorders Treatment Market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Get in touch with our team to get more detailed insights how the MedTech Market is expected to evolve in the coming years and to formulate innovative business solutions, at MedTech Consulting Solutions
Contact Us
Yash Bhardwaj
info@delveinsight.com
+1(919)321-6187